{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T18:08:42Z","timestamp":1773857322007,"version":"3.50.1"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100002839","name":"Charit\u00e9 Universit\u00e4tsmedizin Berlin","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002839","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Berlin Institute of Health"},{"name":"CellTrend"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.cyto.2016.06.021","type":"journal-article","created":{"date-parts":[[2016,6,29]],"date-time":"2016-06-29T18:44:47Z","timestamp":1467225887000},"page":"157-164","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Y-box protein-1\/p18 as novel serum marker for ovarian cancer diagnosis: A study by the Tumor Bank Ovarian Cancer (TOC)"],"prefix":"10.1016","volume":"85","author":[{"given":"Irena","family":"Rohr","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena I.","family":"Braicu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdelaziz","family":"En-Nia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michaela","family":"Heinrich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rolf","family":"Richter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Radoslav","family":"Chekerov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralf","family":"Dechend","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harald","family":"Heidecke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Duska","family":"Dragun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reinhold","family":"Sch\u00e4fer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xenia","family":"Gorny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan A.","family":"Lindquist","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabine","family":"Brandt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jalid","family":"Sehouli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter R.","family":"Mertens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cyto.2016.06.021_b0005","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/bies.950170104","article-title":"A role for Y-box proteins in cell proliferation","volume":"17","author":"Ladomery","year":"1995","journal-title":"BioEssays News Rev. Mol. Cell. Dev. Biol."},{"issue":"13","key":"10.1016\/j.cyto.2016.06.021_b0010","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1134\/S0006297911130049","article-title":"Y-box-binding protein 1 (YB-1) and its functions","volume":"76","author":"Eliseeva","year":"2011","journal-title":"Biochemistry (Mosc)"},{"key":"10.1016\/j.cyto.2016.06.021_b0015","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/bies.10300","article-title":"The pleiotropic functions of the Y-box-binding protein, YB-1","volume":"25","author":"Kohno","year":"2003","journal-title":"BioEssays News Rev. Mol. Cell. Dev. Biol."},{"key":"10.1016\/j.cyto.2016.06.021_b0020","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1349-7006.2003.tb01344.x","article-title":"The basic and clinical implications of ABC transporters, Y-box-binding protein-1 (YB-1) and angiogenesis-related factors in human malignancies","volume":"94","author":"Kuwano","year":"2003","journal-title":"Cancer Sci."},{"key":"10.1016\/j.cyto.2016.06.021_b0025","first-page":"3151","article-title":"Nuclear expression of the Y-box binding protein, YB-1, as a novel marker of disease progression in non-small cell lung cancer","volume":"7","author":"Shibahara","year":"2001","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"key":"10.1016\/j.cyto.2016.06.021_b0030","doi-asserted-by":"crossref","first-page":"E142","DOI":"10.1111\/j.1464-410X.2010.09810.x","article-title":"Twist1 and Y-box-binding protein-1 promote malignant potential in bladder cancer cells","volume":"108","author":"Shiota","year":"2011","journal-title":"BJU Int."},{"key":"10.1016\/j.cyto.2016.06.021_b0035","doi-asserted-by":"crossref","first-page":"e1001231","DOI":"10.1371\/journal.pgen.1001231","article-title":"Identification of Y-box binding protein 1 as a core regulator of MEK\/ERK pathway-dependent gene signatures in colorectal cancer cells","volume":"6","author":"J\u00fcrchott","year":"2010","journal-title":"PLoS Genet."},{"key":"10.1016\/j.cyto.2016.06.021_b0040","doi-asserted-by":"crossref","first-page":"35516","DOI":"10.1074\/jbc.M303920200","article-title":"The Y-box-binding protein, YB1, is a potential negative regulator of the p53 tumor suppressor","volume":"278","author":"Lasham","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cyto.2016.06.021_b0045","first-page":"289","article-title":"Y-box-binding protein 1 (YB1) in breast carcinomas: relation to aggressive tumor phenotype and identification of patients at high risk for relapse","volume":"40","author":"Mylona","year":"2014","journal-title":"Eur. J. Surg. Oncol. J. Eur. Soc. Surg. Oncol. Br. Assoc. Surg. Oncol."},{"key":"10.1016\/j.cyto.2016.06.021_b0050","first-page":"2473","article-title":"Antiestrogens suppress effects of transforming growth factor-\u03b2 in breast cancer cells via the signaling axis estrogen receptor-\u03b1 and Y-box Binding Protein-1","volume":"33","author":"Popp","year":"2013","journal-title":"Anticancer Res."},{"key":"10.1016\/j.cyto.2016.06.021_b0055","first-page":"607","article-title":"Y-box binding protein, YB-1, as a marker of tumor aggressiveness and response to adjuvant chemotherapy in breast cancer","volume":"26","author":"Huang","year":"2005","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.cyto.2016.06.021_b0060","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1186\/1471-2407-9-410","article-title":"Nuclear detection of Y-box protein-1 (YB-1) closely associates with progesterone receptor negativity and is a strong adverse survival factor in human breast cancer","volume":"9","author":"Dahl","year":"2009","journal-title":"BMC Cancer"},{"key":"10.1016\/j.cyto.2016.06.021_b0065","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/s00432-002-0386-6","article-title":"Increased nuclear localization of transcription factor YB-1 in acquired cisplatin-resistant ovarian cancer","volume":"128","author":"Yahata","year":"2002","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.cyto.2016.06.021_b0070","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1093\/jnci\/djt210","article-title":"Role of focal adhesion kinase in regulating YB-1-mediated paclitaxel resistance in ovarian cancer","volume":"105","author":"Kang","year":"2013","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.cyto.2016.06.021_b0075","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1186\/1471-2407-11-185","article-title":"Y-box protein-1\/p18 fragment identifies malignancies in patients with chronic liver disease","volume":"11","author":"Tacke","year":"2011","journal-title":"BMC Cancer"},{"key":"10.1016\/j.cyto.2016.06.021_b0080","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/embor.2009.81","article-title":"Y-box protein-1 is actively secreted through a non-classical pathway and acts as an extracellular mitogen","volume":"10","author":"Frye","year":"2009","journal-title":"EMBO Rep."},{"key":"10.1016\/j.cyto.2016.06.021_b0085","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1093\/jnci\/djg036","article-title":"A randomized clinical trial of cisplatin\/paclitaxel versus carboplatin\/paclitaxel as first-line treatment of ovarian cancer","volume":"95","author":"du Bois","year":"2003","journal-title":"J. Natl Cancer Inst."},{"key":"10.1016\/j.cyto.2016.06.021_b0090","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1002\/cncr.24149","volume":"115","author":"du Bois","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.cyto.2016.06.021_b0095","first-page":"473","article-title":"Platin sensitivity and long-term survival in Stage III epithelial ovarian cancer patients","volume":"29","author":"Menczer","year":"2008","journal-title":"Eur. J. Gynaecol. Oncol."},{"key":"10.1016\/j.cyto.2016.06.021_b0100","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1056\/NEJMra041842","article-title":"Cancer of the ovary","volume":"351","author":"Cannistra","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cyto.2016.06.021_b0105","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/nrc4019","article-title":"Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer","volume":"15","author":"Bowtell","year":"2015","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.cyto.2016.06.021_b0110","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1055\/s-2003-41864","article-title":"\u201cIMO\u201d \u2013 intraoperative mapping of ovarian cancer","volume":"125","author":"Sehouli","year":"2003","journal-title":"Zentralbl. Gyn\u00e4kol."},{"key":"10.1016\/j.cyto.2016.06.021_b0115","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/IGC.0b013e3182070f17","article-title":"Definitions for response and progression in ovarian cancer clinical trials incorporating RECIST 1.1 and CA 125 agreed by the Gynecological Cancer Intergroup (GCIG)","volume":"21","author":"Rustin","year":"2011","journal-title":"Int. J. Gynecol. Cancer Off. J. Int. Gynecol. Cancer Soc."},{"key":"10.1016\/j.cyto.2016.06.021_b0120","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1016\/S0090-8258(03)00471-2","article-title":"Optimal sequencing in the treatment of recurrent ovarian cancer","volume":"90","author":"Spriggs","year":"2003","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.cyto.2016.06.021_b0125","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1097\/GCO.0000000000000135","article-title":"FIGO 2013 staging system for ovarian cancer: what is new in comparison to the 1988 staging system?","volume":"27","author":"Kandukuri","year":"2015","journal-title":"Curr. Opin. Obstet. Gynecol."},{"key":"10.1016\/j.cyto.2016.06.021_b0130","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/bimj.200410135","article-title":"Estimation of the Youden Index and its associated cutoff point","volume":"47","author":"Fluss","year":"2005","journal-title":"Biometr. J."},{"key":"10.1016\/j.cyto.2016.06.021_b0135","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1038\/nrc1753","article-title":"Oncogenic PI3K deregulates transcription and translation","volume":"5","author":"Bader","year":"2005","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.cyto.2016.06.021_b0140","doi-asserted-by":"crossref","first-page":"4078","DOI":"10.1158\/0008-5472.CAN-04-4056","article-title":"YB-1 provokes breast cancer through the induction of chromosomal instability that emerges from mitotic failure and centrosome amplification","volume":"65","author":"Bergmann","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.cyto.2016.06.021_b0145","doi-asserted-by":"crossref","first-page":"8837","DOI":"10.1158\/1078-0432.CCR-05-0945","article-title":"Increased nuclear localization of transcription factor Y-box binding protein 1 accompanied by up-regulation of P-glycoprotein in breast cancer pretreated with paclitaxel","volume":"11","author":"Fujita","year":"2005","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"issue":"Suppl. 3","key":"10.1016\/j.cyto.2016.06.021_b0150","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1525-1438.2005.00441.x","article-title":"New tumor markers: CA125 and beyond","volume":"15","author":"Bast","year":"2005","journal-title":"Int. J. Gynecol. Cancer Off. J. Int. Gynecol. Cancer Soc."},{"key":"10.1016\/j.cyto.2016.06.021_b0155","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJM198310133091503","article-title":"A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer","volume":"309","author":"Bast","year":"1983","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cyto.2016.06.021_b0160","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.ygyno.2008.05.006","article-title":"The epidemiology of CA-125 in women without evidence of ovarian cancer in the Prostate, Lung, Colorectal and Ovarian Cancer (PLCO) screening trial","volume":"110","author":"Johnson","year":"2008","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.cyto.2016.06.021_b0165","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1111\/j.1525-1438.2005.00130.x","article-title":"CA125 in ovarian cancer: European group on tumor markers guidelines for clinical use","volume":"15","author":"Duffy","year":"2005","journal-title":"Int. J. Gynecol. Cancer Off. J. Int. Gynecol. Cancer Soc."},{"key":"10.1016\/j.cyto.2016.06.021_b0170","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/GRF.0b013e3182460c0d","article-title":"Ovarian cancer screening","volume":"55","author":"van Nagell","year":"2012","journal-title":"Clin. Obstet. Gynecol."},{"key":"10.1016\/j.cyto.2016.06.021_b0175","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1146\/annurev-physiol-030212-183653","article-title":"Aging, cellular senescence, and cancer","volume":"75","author":"Campisi","year":"2013","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.cyto.2016.06.021_b0180","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1471-2407-14-33","article-title":"High prevalence of Y-box protein-1\/p18 fragment in plasma of patients with malignancies of different origin","volume":"14","author":"Tacke","year":"2014","journal-title":"BMC Cancer"}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466616301491?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466616301491?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,10]],"date-time":"2018-09-10T17:26:25Z","timestamp":1536600385000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466616301491"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":36,"alternative-id":["S1043466616301491"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2016.06.021","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Y-box protein-1\/p18 as novel serum marker for ovarian cancer diagnosis: A study by the Tumor Bank Ovarian Cancer (TOC)","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2016.06.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}